Product Information
TIMOLOL 0.5% EYE DROP is a generic product labeled by Oceanside Pharmaceuticals, priced at $17.7216 per ML under NDC 68682004550. Its NADAC has been published 364 times since Oct 17, 2018.
FDA first approved this application on Jun 4, 2004. Its Orange Book therapeutic-equivalence code is AT2.
The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Oceanside PharmaceuticalsNDC
68682004550
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/17/2025
Active Ingredients
TIMOLOL MALEATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021516FDA Approved
6/4/2004
TE Code
AT2
On Market Since
5/30/2018
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL 0.5% EYE DROP has been published 364 times since Oct 17, 2018, and over the history we have for it it has declined 55.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.7216 per ML |
|---|---|
| All-time high | $45.1737 (May 13, 2020) |
| All-time low | $11.1775 (May 22, 2024) |
| Median price | $31.3164 |
| Average price | $31.7433 |
| Largest weekly change | -43.2% (May 22, 2024) |
| Weeks tracked | 364 |
| Tracking since | Oct 17, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-39.5%
5Y
-47.2%
All
-55.7%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL 0.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL 0.5% EYE DROP, manufactured by Oceanside Pharmaceuticals, is $17.7216 per ML (NDC 68682004550), effective Oct 1, 2025.
How has the price of TIMOLOL 0.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for TIMOLOL 0.5% EYE DROP has declined 55.7%. It has been tracked across 364 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for TIMOLOL 0.5% EYE DROP?
Since Oct 17, 2018, the NADAC for TIMOLOL 0.5% EYE DROP has ranged from a low of $11.1775 (May 22, 2024) to a high of $45.1737 (May 13, 2020), with a median of $31.3164 per ML.
Are there cheaper alternatives to TIMOLOL 0.5% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TIMOLOL 0.5% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures TIMOLOL 0.5% EYE DROP?
TIMOLOL 0.5% EYE DROP (NDC 68682004550) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.